Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
or
PHASE 1 TRIAL OF p28 (NSC745104), A NON-HDM2 MEDIATED PEPTIDE INHIBITOR OF p53 UBIQUITINATION IN CHILDREN WITH RECURRENT OR PROGRESSIVE CNS TUMORS: A PEDIATRIC BRAIN TUMOR CONSORTIUM REPORT
ÌÇÐÄ´«Ã½
PHASE 1 TRIAL OF p28 (NSC745104), A NON-HDM2 MEDIATED PEPTIDE INHIBITOR OF p53 UBIQUITINATION IN CHILDREN WITH RECURRENT OR PROGRESSIVE CNS TUMORS: A PEDIATRIC BRAIN TUMOR CONSORTIUM REPORT Lulla, R. R., Goldman, S., Beattie, C., DasGupta, T. K., Pollack, I., Fisher, P., Wu, S., Boyett, J. M., Fouladi, M. OXFORD UNIV PRESS INC. 2014: 11View details for